These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19408671)

  • 1. [Relationship of single nucleotide polymorphism, environmental factors and the hereditary susceptibility of hepatocellular carcinoma].
    Ji L; Yu H
    Wei Sheng Yan Jiu; 2009 Mar; 38(2):233-7. PubMed ID: 19408671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Kim YJ; Lee HS
    Intervirology; 2005; 48(1):10-5. PubMed ID: 15785084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
    Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
    Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
    Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
    Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection].
    Kim YJ; Lee HS
    Korean J Hepatol; 2009 Mar; 15(1):7-14. PubMed ID: 19346781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers-hepatocellular carcinoma and cervical cancer.
    Hu L; Liu J; Chen X; Zhang Y; Liu L; Zhu J; Chen J; Shen H; Qiang F; Hu Z
    Hum Immunol; 2010 Sep; 71(9):888-91. PubMed ID: 20538028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study about the association of detoxication gene GSTM1 polymorphism and the susceptibility to aflatoxin B1-related hepatocellular carcinoma].
    Long XD; Ma Y; Wei YP; Deng ZL
    Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):668-70. PubMed ID: 16174455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [p53 gene mutation in hepatocellular carcinoma].
    Jiang W; Lu Q; Pan G
    Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
    Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS
    Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans.
    McGlynn KA; Hunter K; LeVoyer T; Roush J; Wise P; Michielli RA; Shen FM; Evans AA; London WT; Buetow KH
    Cancer Res; 2003 Aug; 63(15):4594-601. PubMed ID: 12907637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma.
    Yeh CB; Tsai HT; Chen YC; Kuo WH; Chen TY; Hsieh YH; Chou MC; Yang SF
    J Surg Oncol; 2010 Sep; 102(3):264-70. PubMed ID: 20740585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
    Kato N; Ji G; Wang Y; Baba M; Hoshida Y; Otsuka M; Taniguchi H; Moriyama M; Dharel N; Goto T; Shao RX; Matsuura T; Ishii K; Shiina S; Kawabe T; Muramatsu M; Omata M
    Hepatology; 2005 Oct; 42(4):846-53. PubMed ID: 16175604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
    J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic polymorphism of UDP-glucuronosyltransferase 1F and susceptibility to hepatocellular carcinoma].
    Liu C; Bian J; Jiang F; Shen F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):324-8. PubMed ID: 12170472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. -509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Chen YM; Wang H; Fang M; Ji Q; Zhao YP; Sun XJ; Liu Y; Gao CF
    Cancer Immunol Immunother; 2009 Sep; 58(9):1433-40. PubMed ID: 19169878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPP1 polymorphisms associated with HBV clearance and HCC occurrence.
    Shin HD; Park BL; Cheong HS; Yoon JH; Kim YJ; Lee HS
    Int J Epidemiol; 2007 Oct; 36(5):1001-8. PubMed ID: 17496055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular aspects of hepatocellular carcinoma].
    Moradpour D; Blum HE
    Zentralbl Chir; 2000; 125(7):592-6. PubMed ID: 10960967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.